# COMBINE (Acamprosate/Naltrexone)

> **NCT00006206** · PHASE3 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 1375 (—)

## Conditions studied

- Alcoholism

## Interventions

- **DRUG:** naltrexone (Revia)
- **DRUG:** acamprosate (Campral)

## Key facts

- **NCT ID:** NCT00006206
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-08
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 1375 (—)
- **Last updated:** 2010-05-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006206, "COMBINE (Acamprosate/Naltrexone)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00006206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*